CN105168701A - Traditional Chinese medicine composite for treating polycystic ovarian syndrome - Google Patents
Traditional Chinese medicine composite for treating polycystic ovarian syndrome Download PDFInfo
- Publication number
- CN105168701A CN105168701A CN201510728432.9A CN201510728432A CN105168701A CN 105168701 A CN105168701 A CN 105168701A CN 201510728432 A CN201510728432 A CN 201510728432A CN 105168701 A CN105168701 A CN 105168701A
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- chinese medicine
- rhizoma
- semen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composite for treating the polycystic ovarian syndrome. The traditional Chinese medicine composite is prepared from, by weight, 15-25 parts of liquidambar formosana hance, 15-25 parts of semen cuscutae, 15-25 parts of arisaema cum bile, 10-15 parts of purple perilla, 10-15 parts of radix rehmanniae praeparata, 10-15 parts of fresh ginger, 10-15 parts of fructus viticis, 10-15 parts of snakegourd peel, 5-10 parts of mangnolia officinalis, 5-10 parts of paeonia suffruticosa bark, 10-15 parts of indigo naturalis, 10-15 parts of codonopsis pilosula, 5-10 parts of semen cassia, 5-10 parts of ligusticum wallichii, 5-10 parts of semen brassicae, 5-10 parts of fructus evodiae, 5-10 parts of galangal, 5-10 parts of uncaria, 15-25 parts of rhizoma sparganii, 15-25 parts of kudzu vine roots, 10-15 parts of astragalus membranaceus, 10-15 parts of mulberries and 5-10 parts of glossy privet fruits. The traditional Chinese medicine composite can promote blood circulation to remove blood stasis, resolve hard lumps, tonify qi and nourish yin, promote qi circulation and relieve depression, tonify spleen and calm heart, regulate menstruation and assist pregnancy, can be used for treating the polycystic ovarian syndrome, and is safe, free of toxic and side effects, and remarkable in treatment effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, in particular to a kind of Chinese medicine composition for the treatment of polycystic ovary syndrome.
Background technology
Polycystic ovary syndrome (PCOS) is a kind of reproductive dysfunction and abnormal carbohydrate metabolism and the endocrine regulation syndrome deposited, be fall ill many because of property, clinical symptoms a kind of endocrine syndrome that be polymorphism is principal character, patient shows as the immature and insulin resistant of Hyperandrogenism in body, chronic anovulation state, many follicles more, is cause one of modal reason of Women of childbearing age menoxenia.The visible hypomenorrhea of patient clinical symptom or amenorrhea, infertile, hirsutism and obesity etc., bilateral ovaries is that many capsules sample increases.
According to the clinical manifestation of polycystic ovary syndrome, Chinese medicine " amenorrhea ", " metrorrhagia ", “ WEIJIA can be attributed to " etc. disease category, its Etiological for suffering from a deficiency of the kidney, stagnation of phlegm-damp, stagnated heat of liver channel, qi depression to blood stasis.Have in " female section highly necessary " " people's amenorrhea, must be phlegm-damp and adipose membrane be jammed therefore " discussion, also have the relevant discussion of " because body contains abundant expectoration, adipose membrane is jammed infertile in born of the same parents " in " Yizong Jinjian gynecological heart method gist ".
The means of current treatment polycystic ovary syndrome, mainly comprise general treatment (reduction body weight), Drug therapy (promoting ovulation drug, the medicine improving insulin resistant, androgen antagonist medicine) and operative treatment, but equal Shortcomings part.The advantages such as treatment by Chinese herbs polycystic ovary syndrome has treating both the principal and secondary aspects of a disease, side effect is little, and treatment cost is low, are subject to the favor of extensive patients day by day.
Summary of the invention
The invention provides a kind of Chinese medicine composition for the treatment of polycystic ovary syndrome, based on the dialectical prescription of tcm theory, there is effect of blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, boosting qi and nourishing yin, promoting QI circulation for relieving depression, spleen invigorating mind calming, regulating menstruation and assisting pregnancy, can be used for treating polycystic ovary syndrome, drug safety, have no side effect, therapeutic effect is remarkable.
Concrete, one aspect of the present invention provides a kind of Chinese medicine composition for the treatment of polycystic ovary syndrome, is made up: Fructus Liquidambaris, Semen Cuscutae, Arisaema Cum Bile of the crude drug of following weight portion.
In the embodiment that the present invention one is concrete, described a kind of Chinese medicine composition for the treatment of polycystic ovary syndrome is made up of the crude drug of following weight portion: Fructus Liquidambaris 15-25 part, Semen Cuscutae 15-25 part, Arisaema Cum Bile 15-25 part.
In the embodiment that the present invention one is concrete, described a kind of Chinese medicine composition for the treatment of polycystic ovary syndrome is made up of the crude drug of following weight portion: Fructus Liquidambaris 15-25 part, Semen Cuscutae 15-25 part, Arisaema Cum Bile 15-25 part, Folium Perillae 10-15 part, Radix Rehmanniae Preparata 10-15 part, Rhizoma Zingiberis Recens 10-15 part, Fructus Viticis 10-15 part, Pericarpium Trichosanthis 10-15 part, Cortex Magnoliae Officinalis 5-10 part, Cortex Moutan 5-10 part, Indigo Naturalis 10-15 part, Radix Codonopsis 10-15 part, Semen Cassiae 5-10 part, Rhizoma Chuanxiong 5-10 part, Semen Sinapis Albae 5-10 part, Fructus Evodiae 5-10 part, Rhizoma Alpiniae Officinarum 5-10 part, Ramulus Uncariae Cum Uncis 5-10 part, Rhizoma Sparganii 15-25 part, Radix Puerariae 15-25 part, Radix Astragali 10-15 part, Fructus Mori 10-15 part, Fructus Ligustri Lucidi 5-10 part.
In the embodiment that the present invention one is concrete, described a kind of Chinese medicine composition for the treatment of polycystic ovary syndrome is made up of the crude drug of following weight portion: Fructus Liquidambaris 20 parts, Semen Cuscutae 15 parts, Arisaema Cum Bile 25 parts, Folium Perillae 12 parts, Radix Rehmanniae Preparata 13 parts, 12 parts, Rhizoma Zingiberis Recens, Fructus Viticis 13 parts, Pericarpium Trichosanthis 15 parts, Cortex Magnoliae Officinalis 8 parts, Cortex Moutan 10 parts, Indigo Naturalis 15 parts, Radix Codonopsis 12 parts, Semen Cassiae 9 parts, Rhizoma Chuanxiong 6 parts, Semen Sinapis Albae 8 parts, Fructus Evodiae 8 parts, Rhizoma Alpiniae Officinarum 5 parts, Ramulus Uncariae Cum Uncis 9 parts, Rhizoma Sparganii 23 parts, Radix Puerariae 24 parts, the Radix Astragali 11 parts, 14 parts, Fructus Mori, Fructus Ligustri Lucidi 6 parts.
In the embodiment that the present invention one is concrete, described a kind of Chinese medicine composition for the treatment of polycystic ovary syndrome is made up of the crude drug of following weight portion: Fructus Liquidambaris 15 parts, Semen Cuscutae 13 parts, Arisaema Cum Bile 22 parts, Folium Perillae 12 parts, Radix Rehmanniae Preparata 11 parts, 14 parts, Rhizoma Zingiberis Recens, Fructus Viticis 13 parts, Pericarpium Trichosanthis 15 parts, Cortex Magnoliae Officinalis 5 parts, Cortex Moutan 6 parts, Indigo Naturalis 13 parts, Radix Codonopsis 11 parts, Semen Cassiae 7 parts, Rhizoma Chuanxiong 6 parts, Semen Sinapis Albae 5 parts, Fructus Evodiae 8 parts, Rhizoma Alpiniae Officinarum 9 parts, Ramulus Uncariae Cum Uncis 10 parts, Rhizoma Sparganii 16 parts, Radix Puerariae 19 parts, the Radix Astragali 14 parts, 11 parts, Fructus Mori, Fructus Ligustri Lucidi 9 parts.
In the embodiment that the present invention one is concrete, described a kind of Chinese medicine composition for the treatment of polycystic ovary syndrome is made up of the crude drug of following weight portion: Fructus Liquidambaris 25 parts, Semen Cuscutae 23 parts, Arisaema Cum Bile 22 parts, Folium Perillae 13 parts, Radix Rehmanniae Preparata 12 parts, 11 parts, Rhizoma Zingiberis Recens, Fructus Viticis 13 parts, Pericarpium Trichosanthis 12 parts, Cortex Magnoliae Officinalis 8 parts, Cortex Moutan 6 parts, Indigo Naturalis 14 parts, Radix Codonopsis 13 parts, Semen Cassiae 9 parts, Rhizoma Chuanxiong 7 parts, Semen Sinapis Albae 8 parts, Fructus Evodiae 10 parts, Rhizoma Alpiniae Officinarum 10 parts, Ramulus Uncariae Cum Uncis 5 parts, Rhizoma Sparganii 25 parts, Radix Puerariae 15 parts, the Radix Astragali 15 parts, 11 parts, Fructus Mori, Fructus Ligustri Lucidi 8 parts.
The present invention provides a kind of preparation method for the treatment of the Chinese medicine composition of polycystic ovary syndrome on the other hand, and it is characterized in that, the preparation method of this Chinese medicine composition comprises the following steps:
(1) Rhizoma Chuanxiong steam distillation extracts volatile oil, obtains mixture of volatile oil, and it is for subsequent use to collect aqueous solution;
(2) Semen Cuscutae, Folium Perillae, Radix Rehmanniae Preparata, Fructus Viticis, Cortex Moutan, Indigo Naturalis, Radix Codonopsis, Rhizoma Alpiniae Officinarum, Radix Puerariae, Fructus Ligustri Lucidi are added soak by water 2-3 time accounting for gross weight 8-15 times amount, each 1.5-2 hour, collecting decoction, add the aqueous solution that step (1) obtains again, filter, relative density when filtrate is concentrated into 80 DEG C is the extractum (I) of 1.15-1.25;
(3) Fructus Liquidambaris, Arisaema Cum Bile, Rhizoma Zingiberis Recens, Pericarpium Trichosanthis, Cortex Magnoliae Officinalis, Semen Cassiae, Semen Sinapis Albae, Fructus Evodiae, Ramulus Uncariae Cum Uncis, Rhizoma Sparganii, the Radix Astragali, Fructus Mori are added account for gross weight 8-15 times amount 85% alcoholic solution in extract 2-3 time, each 2-3 hour, filter, merging filtrate, placement is spent the night, reclaim ethanol, relative density when filtrate being concentrated into 60 DEG C is the extractum (II) of 1.15-1.25;
(4) by step (2), the mixing of (3) gained extractum, dry, and in add the volatile oil of step (1), stir, to obtain final product.
In a concrete embodiment of the present invention, wherein add the soak by water 3 times accounting for gross weight 10 times amount in step (2), each 1.5 hours; Account in step (3) in the alcoholic solution of 85% of gross weight 10 times amount and extract 2 times, each 3 hours.
A kind of Chinese medicine composition for the treatment of polycystic ovary syndrome of the present invention, also can soak by water method or directly pulverize method preparation.The conventional method of Chinese medicine preparation can be adopted to be prepared into any traditional oral preparation.Described oral formulations is capsule, pill, powder, tablet, granule.
Chinese medicine composition of the present invention, based on the dialectical prescription of tcm theory, has effect of blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, boosting qi and nourishing yin, promoting QI circulation for relieving depression, spleen invigorating mind calming, regulating menstruation and assisting pregnancy, can be used for treating polycystic ovary syndrome, drug safety, has no side effect, and therapeutic effect is remarkable.
In the present invention, unit of weight can be the arbitrary unit of weight such as gram, kilogram.
Detailed description of the invention
Embodiment 1:
Treat a Chinese medicine composition for polycystic ovary syndrome, be made up of the crude drug of following weight portion: Fructus Liquidambaris 20 parts, Semen Cuscutae 20 parts, Arisaema Cum Bile 20 parts, Folium Perillae 13 parts, Radix Rehmanniae Preparata 12 parts, 12 parts, Rhizoma Zingiberis Recens, Fructus Viticis 13 parts, Pericarpium Trichosanthis 12 parts, Cortex Magnoliae Officinalis 8 parts, Cortex Moutan 7 parts, Indigo Naturalis 12 parts, Radix Codonopsis 13 parts, Semen Cassiae 7 parts, Rhizoma Chuanxiong 8 parts, Semen Sinapis Albae 7 parts, Fructus Evodiae 8 parts, Rhizoma Alpiniae Officinarum 7 parts, Ramulus Uncariae Cum Uncis 7 parts, Rhizoma Sparganii 20 parts, Radix Puerariae 20 parts, the Radix Astragali 12 parts, 13 parts, Fructus Mori, Fructus Ligustri Lucidi 8 parts;
Take said medicine by formula ratio, be added to the water, boil, slow fire boiling 30 minutes, filter, filtering residue adds water again, slow fire boiling 30 minutes, merge twice medicinal liquid, to obtain final product.
Embodiment 2:
Treat a Chinese medicine composition for polycystic ovary syndrome, be made up of the crude drug of following weight portion: Fructus Liquidambaris 20 parts, Semen Cuscutae 20 parts, Arisaema Cum Bile 20 parts, Folium Perillae 13 parts, Radix Rehmanniae Preparata 12 parts, 12 parts, Rhizoma Zingiberis Recens, Fructus Viticis 13 parts, Pericarpium Trichosanthis 12 parts, Cortex Magnoliae Officinalis 8 parts, Cortex Moutan 7 parts, Indigo Naturalis 12 parts, Radix Codonopsis 13 parts, Semen Cassiae 7 parts, Rhizoma Chuanxiong 8 parts, Semen Sinapis Albae 7 parts, Fructus Evodiae 8 parts, Rhizoma Alpiniae Officinarum 7 parts, Ramulus Uncariae Cum Uncis 7 parts, Rhizoma Sparganii 20 parts, Radix Puerariae 20 parts, the Radix Astragali 12 parts, 13 parts, Fructus Mori, Fructus Ligustri Lucidi 8 parts;
Preparation method comprises the following steps:
(1) Rhizoma Chuanxiong steam distillation extracts volatile oil, obtains mixture of volatile oil, and it is for subsequent use to collect aqueous solution;
(2) Semen Cuscutae, Folium Perillae, Radix Rehmanniae Preparata, Fructus Viticis, Cortex Moutan, Indigo Naturalis, Radix Codonopsis, Rhizoma Alpiniae Officinarum, Radix Puerariae, Fructus Ligustri Lucidi are added soak by water 2-3 time accounting for gross weight 8-15 times amount, each 1.5-2 hour, collecting decoction, add the aqueous solution that step (1) obtains again, filter, relative density when filtrate is concentrated into 80 DEG C is the extractum (I) of 1.15-1.25;
(3) Fructus Liquidambaris, Arisaema Cum Bile, Rhizoma Zingiberis Recens, Pericarpium Trichosanthis, Cortex Magnoliae Officinalis, Semen Cassiae, Semen Sinapis Albae, Fructus Evodiae, Ramulus Uncariae Cum Uncis, Rhizoma Sparganii, the Radix Astragali, Fructus Mori are added account for gross weight 8-15 times amount 85% alcoholic solution in extract 2-3 time, each 2-3 hour, filter, merging filtrate, placement is spent the night, reclaim ethanol, relative density when filtrate being concentrated into 60 DEG C is the extractum (II) of 1.15-1.25;
(4) by step (2), the mixing of (3) gained extractum, dry, and in add the volatile oil of step (1), stir, incapsulate and get final product.
Embodiment 3:
Treat a Chinese medicine composition for polycystic ovary syndrome, be made up of the crude drug of following weight portion: Fructus Liquidambaris 20 parts, Semen Cuscutae 20 parts, Arisaema Cum Bile 20 parts, Folium Perillae 13 parts, Radix Rehmanniae Preparata 12 parts, 12 parts, Rhizoma Zingiberis Recens, Fructus Viticis 13 parts, Pericarpium Trichosanthis 12 parts, Cortex Magnoliae Officinalis 8 parts, Cortex Moutan 7 parts, Indigo Naturalis 12 parts, Radix Codonopsis 13 parts, Semen Cassiae 7 parts, Rhizoma Chuanxiong 8 parts, Semen Sinapis Albae 7 parts, Fructus Evodiae 8 parts, Rhizoma Alpiniae Officinarum 7 parts, Ramulus Uncariae Cum Uncis 7 parts, Rhizoma Sparganii 20 parts, Radix Puerariae 20 parts, the Radix Astragali 12 parts, 13 parts, Fructus Mori, Fructus Ligustri Lucidi 8 parts;
Each crude drug is dry at 45 DEG C, be cooled to room temperature, pulverize state, and mix homogeneously, load snap fit capsule, to obtain final product.
Embodiment 4:
Treat a Chinese medicine composition for polycystic ovary syndrome, be made up of the crude drug of following weight portion: Fructus Liquidambaris 16 parts, Semen Cuscutae 20 parts, Arisaema Cum Bile 17 parts, Folium Perillae 14 parts, Radix Rehmanniae Preparata 11 parts, 13 parts, Rhizoma Zingiberis Recens, Fructus Viticis 12 parts, Pericarpium Trichosanthis 14 parts, Cortex Magnoliae Officinalis 6 parts, Cortex Moutan 9 parts, Indigo Naturalis 11 parts, Radix Codonopsis 14 parts, Semen Cassiae 6 parts, Rhizoma Chuanxiong 9 parts, Semen Sinapis Albae 7 parts, Fructus Evodiae 8 parts, Rhizoma Alpiniae Officinarum 5 parts, Ramulus Uncariae Cum Uncis 10 parts, Rhizoma Sparganii 16 parts, Radix Puerariae 23 parts, the Radix Astragali 10 parts, 15 parts, Fructus Mori, Fructus Ligustri Lucidi 6 parts
Take said medicine by formula ratio, be added to the water, boil, slow fire boiling 30 minutes, filter, filtering residue adds water again, slow fire boiling 30 minutes, merge twice medicinal liquid, to obtain final product.
Embodiment 5:
Treat a Chinese medicine composition for polycystic ovary syndrome, be made up of the crude drug of following weight portion: Fructus Liquidambaris 23 parts, Semen Cuscutae 22 parts, Arisaema Cum Bile 21 parts, Folium Perillae 11 parts, Radix Rehmanniae Preparata 15 parts, 10 parts, Rhizoma Zingiberis Recens, Fructus Viticis 14 parts, Pericarpium Trichosanthis 11 parts, Cortex Magnoliae Officinalis 5 parts, Cortex Moutan 10 parts, Indigo Naturalis 15 parts, Radix Codonopsis 11 parts, Semen Cassiae 8 parts, Rhizoma Chuanxiong 6 parts, Semen Sinapis Albae 9 parts, Fructus Evodiae 6 parts, Rhizoma Alpiniae Officinarum 8 parts, Ramulus Uncariae Cum Uncis 6 parts, Rhizoma Sparganii 21 parts, Radix Puerariae 17 parts, the Radix Astragali 14 parts, 11 parts, Fructus Mori, Fructus Ligustri Lucidi 8 parts;
Take said medicine by formula ratio, be added to the water, boil, slow fire boiling 30 minutes, filter, filtering residue adds water again, slow fire boiling 30 minutes, merge twice medicinal liquid, to obtain final product.
Embodiment 6 clinical data
1, physical data
Choose 100 routine polycystic ovary syndrome patients, age 24-38 year.Diagnostic criteria: adopt the Committee of Experts of (ESHRE/ASRM) Rotterdam of European human reproductions in 2003 and embryo and reproductive medicine association of the U.S. to discuss the standard of recommending.(1) rarely for a long time ovum or anovulation is sent a manuscript to the compositor: menophania can not set up irregular menstrual in 2 years; Amenorrhea (menopause more than 3 months, irregular or menstrual cycle >=6 of menstrual cycle month in the past); Hypomenorrhea >=35 day and annual >=3 months not ovulation persons; (2) hyperandrogenism, has clinical foundation and/or biochemical foundation; (3) ovary polycystic change: follicle >=12 of side or bilateral ovaries diameter 2-9mm, and (or) Ovarian Volume >=10ml; Meet 2 in above-mentioned 3, and get rid of other high androgen causes of disease and can make a definite diagnosis.
2, Therapeutic Method
Get herb liquid obtained in the embodiment of the present invention 1 to treat, within the 5th day, take medicine from menstrual cycle, every day, potion, serve on 10 days, within 1 month, once, took 3 months.
3, efficacy assessment standard
Cure: menstrual cycle rule, ovulation is normal, and B ultrasonic display ovary recovers normal, and hormone checks that indices display is normal, or conceived;
Effective: menstrual cycle rule, has ovulation, B ultrasonic display ovary is gradually multiple, and hormone determination LH/FSH reduces;
Invalid: B ultrasonic and lab testing are without change, and menstruation and ovulation make moderate progress but still abnormal or be not any change.
4, result
After 3 months, cure 31 examples, effective 48 examples, effective 20 examples, invalid 1 example, the total effective rate of traditional Chinese medicine composition for treating polycystic ovary syndrome of the present invention reaches 99%, and any untoward reaction does not all appear in each case.
Claims (8)
1. treat a Chinese medicine composition for polycystic ovary syndrome, be made up of the crude drug of following weight portion: Fructus Liquidambaris, Semen Cuscutae, Arisaema Cum Bile.
2. a kind of Chinese medicine composition for the treatment of polycystic ovary syndrome according to claim 1, is made up of the crude drug of following weight portion: Fructus Liquidambaris 15-25 part, Semen Cuscutae 15-25 part, Arisaema Cum Bile 15-25 part.
3. a kind of Chinese medicine composition for the treatment of polycystic ovary syndrome according to claim 1, be made up of the crude drug of following weight portion: Fructus Liquidambaris 15-25 part, Semen Cuscutae 15-25 part, Arisaema Cum Bile 15-25 part, Folium Perillae 10-15 part, Radix Rehmanniae Preparata 10-15 part, Rhizoma Zingiberis Recens 10-15 part, Fructus Viticis 10-15 part, Pericarpium Trichosanthis 10-15 part, Cortex Magnoliae Officinalis 5-10 part, Cortex Moutan 5-10 part, Indigo Naturalis 10-15 part, Radix Codonopsis 10-15 part, Semen Cassiae 5-10 part, Rhizoma Chuanxiong 5-10 part, Semen Sinapis Albae 5-10 part, Fructus Evodiae 5-10 part, Rhizoma Alpiniae Officinarum 5-10 part, Ramulus Uncariae Cum Uncis 5-10 part, Rhizoma Sparganii 15-25 part, Radix Puerariae 15-25 part, Radix Astragali 10-15 part, Fructus Mori 10-15 part, Fructus Ligustri Lucidi 5-10 part.
4. a kind of Chinese medicine composition for the treatment of polycystic ovary syndrome according to claim 1, is made up of the crude drug of following weight portion: Fructus Liquidambaris 20 parts, Semen Cuscutae 15 parts, Arisaema Cum Bile 25 parts, Folium Perillae 12 parts, Radix Rehmanniae Preparata 13 parts, 12 parts, Rhizoma Zingiberis Recens, Fructus Viticis 13 parts, Pericarpium Trichosanthis 15 parts, Cortex Magnoliae Officinalis 8 parts, Cortex Moutan 10 parts, Indigo Naturalis 15 parts, Radix Codonopsis 12 parts, Semen Cassiae 9 parts, Rhizoma Chuanxiong 6 parts, Semen Sinapis Albae 8 parts, Fructus Evodiae 8 parts, Rhizoma Alpiniae Officinarum 5 parts, Ramulus Uncariae Cum Uncis 9 parts, Rhizoma Sparganii 23 parts, Radix Puerariae 24 parts, the Radix Astragali 11 parts, 14 parts, Fructus Mori, Fructus Ligustri Lucidi 6 parts.
5. a kind of Chinese medicine composition for the treatment of polycystic ovary syndrome according to claim 1, is made up of the crude drug of following weight portion: Fructus Liquidambaris 15 parts, Semen Cuscutae 13 parts, Arisaema Cum Bile 22 parts, Folium Perillae 12 parts, Radix Rehmanniae Preparata 11 parts, 14 parts, Rhizoma Zingiberis Recens, Fructus Viticis 13 parts, Pericarpium Trichosanthis 15 parts, Cortex Magnoliae Officinalis 5 parts, Cortex Moutan 6 parts, Indigo Naturalis 13 parts, Radix Codonopsis 11 parts, Semen Cassiae 7 parts, Rhizoma Chuanxiong 6 parts, Semen Sinapis Albae 5 parts, Fructus Evodiae 8 parts, Rhizoma Alpiniae Officinarum 9 parts, Ramulus Uncariae Cum Uncis 10 parts, Rhizoma Sparganii 16 parts, Radix Puerariae 19 parts, the Radix Astragali 14 parts, 11 parts, Fructus Mori, Fructus Ligustri Lucidi 9 parts.
6. a kind of Chinese medicine composition for the treatment of polycystic ovary syndrome according to claim 1, is made up of the crude drug of following weight portion: Fructus Liquidambaris 25 parts, Semen Cuscutae 23 parts, Arisaema Cum Bile 22 parts, Folium Perillae 13 parts, Radix Rehmanniae Preparata 12 parts, 11 parts, Rhizoma Zingiberis Recens, Fructus Viticis 13 parts, Pericarpium Trichosanthis 12 parts, Cortex Magnoliae Officinalis 8 parts, Cortex Moutan 6 parts, Indigo Naturalis 14 parts, Radix Codonopsis 13 parts, Semen Cassiae 9 parts, Rhizoma Chuanxiong 7 parts, Semen Sinapis Albae 8 parts, Fructus Evodiae 10 parts, Rhizoma Alpiniae Officinarum 10 parts, Ramulus Uncariae Cum Uncis 5 parts, Rhizoma Sparganii 25 parts, Radix Puerariae 15 parts, the Radix Astragali 15 parts, 11 parts, Fructus Mori, Fructus Ligustri Lucidi 8 parts.
7. a kind of Chinese medicine composition for the treatment of polycystic ovary syndrome according to any one of claim 1-6, is characterized in that, adopts the conventional method of Chinese medicine preparation to be prepared into any traditional oral preparation.
8. a kind of Chinese medicine composition for the treatment of polycystic ovary syndrome according to claim 7, is characterized in that, described oral formulations is capsule, pill, powder, tablet, granule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510728432.9A CN105168701A (en) | 2015-10-30 | 2015-10-30 | Traditional Chinese medicine composite for treating polycystic ovarian syndrome |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510728432.9A CN105168701A (en) | 2015-10-30 | 2015-10-30 | Traditional Chinese medicine composite for treating polycystic ovarian syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105168701A true CN105168701A (en) | 2015-12-23 |
Family
ID=54891456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510728432.9A Pending CN105168701A (en) | 2015-10-30 | 2015-10-30 | Traditional Chinese medicine composite for treating polycystic ovarian syndrome |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105168701A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102895456A (en) * | 2011-07-25 | 2013-01-30 | 刘艳萍 | Drug for treating polycystic ovarian syndrome |
-
2015
- 2015-10-30 CN CN201510728432.9A patent/CN105168701A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102895456A (en) * | 2011-07-25 | 2013-01-30 | 刘艳萍 | Drug for treating polycystic ovarian syndrome |
Non-Patent Citations (2)
| Title |
|---|
| 宁美华等: "益肾消瘕方治疗多囊卵巢综合征85例小结", 《湖南中医药导报》 * |
| 王花: "多囊卵巢综合征的中医药治疗", 《长春中医药大学学报》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN102805841B (en) | Medicament for treating adverse reaction caused by anesthetics | |
| CN101129617A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN1048175C (en) | Oral liquid for regulating women's sexual function | |
| CN101129503A (en) | Traditional Chinese medicine for treating accumulation-cold headache | |
| CN101904985B (en) | Medicament for treating skin itch and preparation method thereof | |
| CN101468188A (en) | Health-care medicament for treating hypertension | |
| CN101912596B (en) | Medicament for treating allergic rhinitis and preparation method thereof | |
| CN101129967A (en) | Traditional Chinese medicine for treating diabetes diarrhea | |
| CN103263650B (en) | Chinese medicament for conditioning female menstruation | |
| CN1329067C (en) | Traditional Chinese medicine prepn. for treating diabetes | |
| CN101099838A (en) | Traditional Chinese medicine for treating female menopausal syndrome | |
| CN105168701A (en) | Traditional Chinese medicine composite for treating polycystic ovarian syndrome | |
| CN103071079B (en) | Traditional Chinese medicinal composition for treating prurigo nodularis | |
| CN105381289A (en) | Pharmaceutical composition for treating abnormal menstruation | |
| CN101569664A (en) | Chinese medicine for treating Raynaud's disease | |
| CN105213467A (en) | A kind of Chinese medicine composition for the treatment of premature ovarian failure | |
| CN103860869A (en) | Traditional Chinese medicine for treating gestational hypertension | |
| CN102366594A (en) | Traditional Chinese medicine for adjusting menstruation | |
| CN101375989B (en) | Anti-inflammation formulation for treating hyperplastic prostate gland and preparation method thereof | |
| CN101874861B (en) | Medicament for treating and preventing heart diseases | |
| CN105194562A (en) | Medicament for treating hepatogenous diabetes | |
| CN102370838B (en) | Kidney-invigorating and tendon-reinforcing double-phase capsule | |
| CN108210873B (en) | Traditional Chinese medicine composition for increasing estrogen and application thereof | |
| CN105412378A (en) | Traditional Chinese medicine composition for treating hyperostosis and cervical spondylosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151223 |